- Posted in Business Critical | June 09, 2012 | Comments (0)
- Tags: financial, company financials, sales
- By: Julie A. Vetalice
Page 1 of 4
ORTHOWORLD’s estimates place overall 2011 market growth at 4% over 2010, as displayed in Exhibit 1. Performance highlights follow and pertain to both 4Q11 and 2011, as indicated.
Exhibit 1: Orthopaedic Sales Increases1 by Product Segment: 2011 vs. 2010
Notes to Exhibit 1
- Orthopaedic products except as indicated; constant currency, pro forma growth
- Includes biologics
- For the quarter ended 11/30/11; includes Dental. Spine includes Bone Stim and Biologics; Bone Stim reflects all Bone Healing sales.
- For the quarter ended 1/27/12
- Spine
- For the quarter ended 12/31/11
- Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient Handling.
- ORTHOWORLD estimates
- For the quarter ended 12/31/11
- Excludes Other (Aerospace)
